Covered recipient · General Payments record
ZERKA WADOOD
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2022–2024
$833.44
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.01 | 11 |
| Education | $78.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $153.12 | 7 |
| ABIOMED | $150.00 | 1 |
| SANOFI-AVENTIS U.S. LLC | $78.99 | 1 |
| GlaxoSmithKline, LLC. | $52.47 | 2 |
| Acerta Pharma LLC | $49.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $150.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142196174 | CMS |
| AstraZeneca Pharmaceuticals LP | $49.42 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105534434 | CMS |
| GENZYME CORPORATION | $4.92 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012482 | CMS |
| GENZYME CORPORATION | $98.10 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012506 | CMS |
| GENZYME CORPORATION | $11.14 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012512 | CMS |
| GENZYME CORPORATION | $5.01 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012516 | CMS |
| GENZYME CORPORATION | $9.33 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012522 | CMS |
| GENZYME CORPORATION | $4.24 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012530 | CMS |
| GENZYME CORPORATION | $20.38 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012538 | CMS |
| GlaxoSmithKline, LLC. | $18.13 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116112508 | CMS |
| GlaxoSmithKline, LLC. | $34.34 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116115022 | CMS |
| SANOFI-AVENTIS U.S. LLC | $78.99 | 08/26/2024 | Education | Undisputed | 01/23/2026 | 1140012492 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.